{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T02:30:54Z","timestamp":1789093854717,"version":"build-2803163510"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins &amp; Other Lipid Mediators"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.prostaglandins.2018.01.001","type":"journal-article","created":{"date-parts":[[2018,2,4]],"date-time":"2018-02-04T08:30:37Z","timestamp":1517733037000},"page":"1-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Zileuton alleviates acute cisplatin nephrotoxicity: Inhibition of lipoxygenase pathway favorably modulates the renal oxidative\/inflammatory\/caspase-3 axis"],"prefix":"10.1016","volume":"135","author":[{"given":"Mai M.","family":"Helmy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amel A.","family":"Hashim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samar M.","family":"Mouneir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prostaglandins.2018.01.001_bib0005","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.3390\/toxins2112490","article-title":"Mechanisms of cisplatin nephrotoxicity","volume":"2","author":"Miller","year":"2010","journal-title":"Toxins (Basel)"},{"issue":"1","key":"10.1016\/j.prostaglandins.2018.01.001_bib0010","doi-asserted-by":"crossref","first-page":"4","DOI":"10.15252\/emmm.201607062","article-title":"After surviving cancer, what about late life effects of the cure?","volume":"9","author":"Nonnekens","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.prostaglandins.2018.01.001_bib0015","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1681\/ASN.V134858","article-title":"Cisplatin induces apoptosis in LLC-PK1 cells via activation of mitochondrial pathways","volume":"13","author":"Park","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.prostaglandins.2018.01.001_bib0020","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/MAJ.0b013e31812dfe1e","article-title":"Cisplatin nephrotoxicity: a review","volume":"334","author":"Yao","year":"2007","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.prostaglandins.2018.01.001_bib0025","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s11010-016-2770-6","article-title":"The increased level of COX-dependent arachidonic acid metabolism in blood platelets from secondary progressive multiple sclerosis patients","volume":"420","author":"Morel","year":"2016","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.prostaglandins.2018.01.001_bib0030","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1124\/mol.66.2.220","article-title":"Reduction of renal ischemia-reperfusion injury in 5-lipoxygenase knockout mice and by the 5-lipoxygenase inhibitor zileuton","volume":"66","author":"Patel","year":"2004","journal-title":"Mol. Pharmacol."},{"issue":"1\u20132","key":"10.1016\/j.prostaglandins.2018.01.001_bib0035","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s10787-006-1496-6","article-title":"The role of leukotrienes in the pathophysiology of inflammatory disorders: is there a case for revisiting leukotrienes as therapeutic targets?","volume":"14","author":"Sharma","year":"2006","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.prostaglandins.2018.01.001_bib0040","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/42506","article-title":"A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis","volume":"387","author":"Yokomizo","year":"1997","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.prostaglandins.2018.01.001_bib0045","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1124\/jpet.116.238824","article-title":"Inhibition of Leukotriene B4 action mitigates intracerebral hemorrhage-associated pathological events in mice","volume":"360","author":"Hijioka","year":"2017","journal-title":"J Pharmacol Exp Ther."},{"key":"10.1016\/j.prostaglandins.2018.01.001_bib0050","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S0008-6363(99)00187-X","article-title":"The role of neutrophils in myocardial ischemia-reperfusion injury","volume":"43","author":"Jordan","year":"1999","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.prostaglandins.2018.01.001_bib0055","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.curtheres.2013.06.001","article-title":"The effects of zileuton and montelukast in reperfusion-induced arrhythmias in anesthetized rats","volume":"75","author":"Gonca","year":"2013","journal-title":"Curr. Ther. Res."},{"key":"10.1016\/j.prostaglandins.2018.01.001_bib0060","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0952-3278(03)00075-9","article-title":"The role of leukotrienes in asthma","volume":"69","author":"Wenzel","year":"2003","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.prostaglandins.2018.01.001_bib0065","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1097\/00005537-199809000-00025","article-title":"Systemic neutrophil intrinsic 5-lipoxygenase activity and CD18 receptor expression linked to reperfusion injury","volume":"108","author":"Dolan","year":"1998","journal-title":"Laryngoscope"},{"key":"10.1016\/j.prostaglandins.2018.01.001_bib0070","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/sj.bjp.0704189","article-title":"Production of leukotrienes in a model of focal cerebral ischemia in the rat","volume":"133","author":"Ciceri","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.prostaglandins.2018.01.001_bib0075","first-page":"F794","article-title":"Postischemic renal injury is mediated by neutrophils and leukotrienes","volume":"256","author":"Klausner","year":"1989","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.prostaglandins.2018.01.001_bib0080","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0022-3565(25)23086-5","article-title":"5-Lipoxygenase inhibitory activity of zileuton","volume":"256","author":"Carter","year":"1991","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.prostaglandins.2018.01.001_bib0085","doi-asserted-by":"crossref","first-page":"10112","DOI":"10.1038\/ncomms10112","article-title":"Leukotriene C4 is the major trigger of stress-induced oxidative DNA damage","volume":"6","author":"Dvash","year":"2015","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.prostaglandins.2018.01.001_bib0090","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1046\/j.1523-1755.2000.00118.x","article-title":"A role for leukotrienes in cyclosporine nephrotoxicity","volume":"57","author":"Butterly","year":"2000","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.prostaglandins.2018.01.001_bib0095","doi-asserted-by":"crossref","first-page":"H342","DOI":"10.1152\/ajpheart.2001.281.1.H342","article-title":"Cysteinyl leukotrienes mediate enhanced vasoconstriction to angiotensin II but not endothelin-1 in SHR","volume":"281","author":"Shastri","year":"2001","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.prostaglandins.2018.01.001_bib0100","doi-asserted-by":"crossref","first-page":"L84","DOI":"10.1152\/ajplung.00446.2003","article-title":"LTD4 induces hyperresponsiveness to histamine in bovine airway smooth muscle: role of SR-ATPase Ca2+ pump and tyrosine kinase","volume":"288","author":"Carbajal","year":"2005","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"issue":"December (12)","key":"10.1016\/j.prostaglandins.2018.01.001_bib0105","first-page":"0167058","article-title":"Pro-resolving effects of resolving D2 in LTD4 and TNF-\u03b1 pre-treated human bronchi","volume":"11","author":"Khaddaj-Mallat","year":"2016","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.prostaglandins.2018.01.001_bib0110","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1293\/tox.23.271","article-title":"Relationship of cell proliferating parker expressions with PGE (2) receptors in regenerating rat renal tubules after cisplatin injection","volume":"23","author":"Yamamoto","year":"2010","journal-title":"J. Toxicol. Pathol."},{"issue":"2","key":"10.1016\/j.prostaglandins.2018.01.001_bib0115","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.bbamcr.2015.11.035","article-title":"Intracellular prostaglandin E2 mediates cisplatin-induced proximal tubular cell death","volume":"1863","author":"Fern\u00e1ndez-Mart\u00ednez","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.prostaglandins.2018.01.001_bib0120","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3109\/0886022X.2011.647305","article-title":"Beneficial effects of montelukast against cisplatin-induced acute renal damage in rats","volume":"34","author":"Beytur","year":"2012","journal-title":"Ren. Fail."},{"issue":"2","key":"10.1016\/j.prostaglandins.2018.01.001_bib0125","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1472-8206.2011.00996.x","article-title":"Montelukast ameliorates kidney function and urinary bladder sensitivity in experimentally induced renal dysfunction in rats","volume":"27","author":"Suddek","year":"2013","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.prostaglandins.2018.01.001_bib0130","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00280-017-3331-8","article-title":"Possible involvement of the lipoxygenase and leukotriene signaling pathways in cisplatin-mediated renal toxicity","volume":"80","author":"Alkhamees","year":"2017","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.prostaglandins.2018.01.001_bib0135","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.fertnstert.2010.08.017","article-title":"Protective effects of montelukast on ischemia-reperfusion injury in rat ovaries subjected to torsion and detorsion: biochemical and histopathologic evaluation","volume":"95","author":"Oral","year":"2011","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.prostaglandins.2018.01.001_bib0140","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.cellsig.2009.09.014","article-title":"The cardioprotective effects of zileuton, a 5-lipoxygenase inhibitor, are mediated by COX-2 via activation of PKC delta","volume":"22","author":"Kwak","year":"2010","journal-title":"Cell Signal."},{"issue":"3","key":"10.1016\/j.prostaglandins.2018.01.001_bib0145","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1476-5381.2010.00930.x","article-title":"The 5-lipoxygenase inhibitor, zileuton, suppresses prostaglandin biosynthesis by inhibition of arachidonic acid release in macrophages","volume":"161","author":"Rossi","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.prostaglandins.2018.01.001_bib0150","first-page":"61","article-title":"Expression of 5-lipoxygenase in hippocampal CA1 neuronal damage following global cerebral ischemia in rats","volume":"42","author":"Chen","year":"2013","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban"},{"key":"10.1016\/j.prostaglandins.2018.01.001_bib0155","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1159\/000353427","article-title":"Effects of zileuton on airway smooth muscle remodeling after repeated allergen challenge in brown norway rats","volume":"86","author":"Chen","year":"2013","journal-title":"Respiration"},{"key":"10.1016\/j.prostaglandins.2018.01.001_bib0160","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1111\/j.1476-5381.2010.00872.x","article-title":"Animal research: reporting in vivo experiments: the ARRIVE guidelines","volume":"160","author":"Kilkenny","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.prostaglandins.2018.01.001_bib0165","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1111\/j.1476-5381.2010.00873.x","article-title":"Guidelines for reporting experiments involving animals: the ARRIVE guidelines","volume":"160","author":"McGrath","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.prostaglandins.2018.01.001_bib0170","doi-asserted-by":"crossref","first-page":"e0142303","DOI":"10.1371\/journal.pone.0142303","article-title":"Additive renoprotection by pioglitazone and fenofibrate against inflammatory, oxidative and apoptotic manifestations of cisplatin nephrotoxicity: modulation by PPARs","volume":"10","author":"Helmy","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.prostaglandins.2018.01.001_bib0175","doi-asserted-by":"crossref","first-page":"273870","DOI":"10.1155\/2014\/273870","article-title":"Renoprotective effect of Egyptian Cape Gooseberry fruit (Physalis peruviana L.) against acute renal injury in rats","volume":"2014","author":"Ahmed","year":"2014","journal-title":"Sci. World J."},{"issue":"3","key":"10.1016\/j.prostaglandins.2018.01.001_bib0180","first-page":"393","article-title":"Role of nitrergic and endothelin pathways modulations in cisplatin-induced nephrotoxicity in male rats","volume":"65","author":"Helmy","year":"2014","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.prostaglandins.2018.01.001_bib0185","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0014-2999(03)01720-5","article-title":"Testosterone depletion contributes to cyclosporine-induced chronic impairment of acetylcholine renovascular relaxations","volume":"468","author":"El-Mas","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.prostaglandins.2018.01.001_bib0190","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.clinbiochem.2012.07.089","article-title":"Influence of fasting and sample collection time on 38 biochemical markers in healthy children: a CALIPER substudy","volume":"45","author":"Pasic","year":"2012","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.prostaglandins.2018.01.001_bib0195","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0009-8981(98)00060-6","article-title":"Determination of nitrite\/nitrate in human biological material by the simple Griess reaction","volume":"274","author":"Guevara","year":"1998","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.prostaglandins.2018.01.001_bib0200","series-title":"Carleton\u2019s Histological Techniques","author":"Drury","year":"1980"},{"key":"10.1016\/j.prostaglandins.2018.01.001_bib0205","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1046\/j.1523-1755.2000.00212.x","article-title":"Tempol, a membrane-permeable radical scavenger, reduces oxidant stress-mediated renal dysfunction and injury in the rat","volume":"58","author":"Chatterjee","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/j.prostaglandins.2018.01.001_bib0210","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ejphar.2012.03.018","article-title":"Montelukast abrogates rhabdomyolysis-induced acute renal failure via rectifying detrimental changes in antioxidant profile and systemic cytokines and apoptotic factors production","volume":"683","author":"Helmy","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.prostaglandins.2018.01.001_bib0215","first-page":"886","article-title":"Effects of intensive cell phone (Philips Genic 900) use on the rat kidney tissue","volume":"10","author":"Koca","year":"2013","journal-title":"Urol. J."},{"issue":"8","key":"10.1016\/j.prostaglandins.2018.01.001_bib0220","first-page":"4607","article-title":"Epigallocatechin-3-gallate protects against cisplatin nephrotoxicity by inhibiting the apoptosis in mouse","volume":"7","author":"Zou","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.prostaglandins.2018.01.001_bib0225","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/j.1365-2222.2007.02692.x","article-title":"Cysteinyl leukotrienes enhance tumour necrosis factor-alpha-induced matrix metalloproteinase-9 in human monocytes\/macrophages","volume":"37","author":"Ichiyama","year":"2007","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.prostaglandins.2018.01.001_bib0230","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.4049\/jimmunol.173.3.1503","article-title":"Immune and inflammatory responses cellular distribution and function in cysteinyl leukotrienes and their receptors","volume":"173","author":"Kanaoka","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.prostaglandins.2018.01.001_bib0235","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1742-7843.2005.pto_114.x","article-title":"Protective effects of L-arginine against cisplatin induced renal oxidative stress and toxicity: role of nitric oxide","volume":"97","author":"Saleh","year":"2005","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"3","key":"10.1016\/j.prostaglandins.2018.01.001_bib0240","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.etp.2008.09.003","article-title":"Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity","volume":"61","author":"Chirino","year":"2009","journal-title":"Exp. Toxicol. Pathol."},{"key":"10.1016\/j.prostaglandins.2018.01.001_bib0245","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1172\/JCI200215606","article-title":"TNF-\u03b1 mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity","volume":"110","author":"Ramesh","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.prostaglandins.2018.01.001_bib0250","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1742-4658.2010.07975.x","article-title":"Regulation of DNA fragmentation: the role of caspases and phosphorylation","volume":"278","author":"Kitazumi","year":"2011","journal-title":"FEBS J."},{"key":"10.1016\/j.prostaglandins.2018.01.001_bib0255","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.regpep.2011.12.001","article-title":"Altered regulation of nitric oxide and natriuretic peptide system in cisplatin-induced nephropathy","volume":"174","author":"Kim","year":"2012","journal-title":"Regul. Pept."},{"issue":"5","key":"10.1016\/j.prostaglandins.2018.01.001_bib0260","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.phymed.2012.12.001","article-title":"Hesperidin attenuates cisplatin-induced acute renal injury by decreasing oxidative stress, inflammation and DNA damage","volume":"20","author":"Sahu","year":"2013","journal-title":"Phytomedicine"},{"key":"10.1016\/j.prostaglandins.2018.01.001_bib0265","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.jss.2008.08.006","article-title":"Protective potential of montelukast against hepatic ischemia\/reperfusion injury in rats","volume":"159","author":"Ozkan","year":"2010","journal-title":"J. Surg. Res."},{"issue":"10","key":"10.1016\/j.prostaglandins.2018.01.001_bib0270","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1007\/s11064-016-1994-x","article-title":"5-LOX inhibitor zileuton reduces inflammatory reaction and ischemic brain damage through the activation of PI3K\/Akt signaling pathway","volume":"41","author":"Tu","year":"2016","journal-title":"Neurochem. Res."},{"issue":"August (8)","key":"10.1016\/j.prostaglandins.2018.01.001_bib0275","doi-asserted-by":"crossref","first-page":"e70991","DOI":"10.1371\/journal.pone.0070991","article-title":"Zileuton improves memory deficits, amyloid and tau pathology in a mouse model of Alzheimer\u2019s disease with plaques and tangles","volume":"8","author":"Chu","year":"2013","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.prostaglandins.2018.01.001_bib0280","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1001\/archotol.124.12.1377","article-title":"In vivo correlation of neutrophil receptor expression, ischemia-reperfusion injury, and selective 5-lipoxygenase inhibition in guinea pigs","volume":"124","author":"Dolan","year":"1998","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"issue":"1","key":"10.1016\/j.prostaglandins.2018.01.001_bib0285","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.phrs.2006.02.007","article-title":"Montelukast protects against renal ischemia\/reperfusion injury in rats","volume":"54","author":"\u015eener","year":"2006","journal-title":"Pharmacol. Res."},{"issue":"5","key":"10.1016\/j.prostaglandins.2018.01.001_bib0290","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S1734-1140(12)70914-3","article-title":"Evaluation of the antioxidative properties of lipoxygenase inhibitors","volume":"64","author":"Czapski","year":"2012","journal-title":"Pharmacol. Rep."}],"container-title":["Prostaglandins &amp; Other Lipid Mediators"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882317300928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882317300928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T14:43:37Z","timestamp":1751294617000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098882317300928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":58,"alternative-id":["S1098882317300928"],"URL":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2018.01.001","relation":{},"ISSN":["1098-8823"],"issn-type":[{"value":"1098-8823","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Zileuton alleviates acute cisplatin nephrotoxicity: Inhibition of lipoxygenase pathway favorably modulates the renal oxidative\/inflammatory\/caspase-3 axis","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins & Other Lipid Mediators","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2018.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}